CEFTROS 1GM INJ
— Product

CEFTROS 1GM INJ

CEFTRIAXONE 1GM INJ

CEFTROS 1GM INJ is an injection of ceftriaxone 1 g, a third-generation cephalosporin given intramuscularly or intravenously. It is used for serious infections — pneumonia, meningitis, septicaemia, complicated urinary tract and intra-abdominal infection, typhoid fever, gonorrhoea and surgical prophylaxis.

01

Benefits

  • Broad Gram-negative and useful Gram-positive cover, and one of the mainstays of empirical therapy in serious community-acquired infection.
  • Penetrates the cerebrospinal fluid well, making it a first-line agent in bacterial meningitis.
  • The long half-life allows once-daily dosing, which is unusual among cephalosporins and simplifies both inpatient and outpatient therapy.
  • Single-dose intramuscular treatment is standard for uncomplicated gonorrhoea.
  • Dual biliary and renal excretion means no dose adjustment is needed in mild to moderate renal impairment.
  • Widely used for surgical prophylaxis and in enteric fever.
02

Side effects

Not everyone gets these. Most are mild and settle as the course finishes.

Common
  • Pain or induration at the injection site
  • Diarrhoea or loose stools
  • Nausea
  • Skin rash
Less common
  • Raised liver enzymes on testing
  • Eosinophilia or low white cell count
  • Biliary sludging, sometimes with right-upper-abdominal discomfort
  • Thrombophlebitis at the infusion site
Stop and get medical help if any of these occur
  • Swelling of the face, lips or tongue, difficulty breathing, or collapse
  • Severe, watery or bloody diarrhoea during or in the weeks after the course
  • Widespread rash with blistering or peeling skin
  • Yellowing of the skin or eyes, or severe right-upper-abdominal pain
  • Reduced urine output or blood in the urine
03

Precautions

  • Contraindicated in neonates receiving or expected to receive calcium-containing intravenous fluids — ceftriaxone-calcium precipitates have caused fatal lung and kidney damage in newborns.
  • Contraindicated in hyperbilirubinaemic neonates and in premature infants, as ceftriaxone displaces bilirubin from albumin.
  • Contraindicated in known cephalosporin allergy; use with caution in penicillin allergy and avoid entirely after penicillin anaphylaxis.
  • Do not mix or co-administer through the same line with calcium-containing solutions, including Ringer's lactate, at any age.
  • Do not mix in the same syringe or line as an aminoglycoside.
  • Biliary sludging can occur, particularly with high doses and prolonged courses — usually reversible on stopping.
  • Dose adjustment is required where both renal and hepatic function are significantly impaired.
  • For administration by a qualified healthcare professional only.